Latest Cover
Welcome to Progress in Neurology and Psychiatry’s dedicated website. Progress is for health professionals in secondary and primary care looking after patients with neurological and psychiatric diseases. If you are a health professional working in the field of neurology or psychiatry you can register with us for free access to our content.Sign up for e-alerts and print copies

Latest News

Email based interventions could improve mental health

Health interventions conducted via email may improve mental health according to a study published in BMC Psychology.Conducted in Finland, the study found...Read more

Amphetamine for ADHD available in US

Dyanavel XR (amphetamine), the first and only extended-release liquid amphetamine for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in...Read more

Daclizumab improves cognition in MS patients

Daclizumab (Zinbryta) improves cognition in patients with Multiple Sclerosis, according to research revealed at the 68th Annual Meeting of the American Academy...Read more

Action urged to tackle smoking in people with mental health conditions

Action on Smoking and Health (ASH) says ‘urgent action’ is needed to tackle the high smoking rate among people with mental health conditions, according a...Read more

Maintenance treatment for schizophrenia recommended

The Committee for Medicinal Products for Human Use has adopted a ‘positive opinion’ recommending paliperidone palmitate for the treatment of...Read more

Featured Articles

Antidepressant drug interactions: evidence and clinical significance
Antidepressants are widely used in the general population, primarily to treat depression but also commonly in conditions such as anxiety disorders and neuropathic pain. This article considers the significant pharmacodynamic and pharmacokinetic drug interactions of different antidepressants…
Click here to view

Clozapine-induced neutropenia reversed by lithium
Clozapine is effective in treating refractory cases of schizophrenia and schizoaffective disorder, however, it can induce the serious side-effect of neutropenia. There is an evolving evidence base in which lithium…
Click here to view

Factors important to psychiatrists when prescribing depot antipsychotics
The relative benefits and disadvantages of first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) has been an area of much interest since SGAs were introduced amidst high expectations of superior efficacy and improved side-effect profiles.
Click here to view

Web design and marketing agency Leamington Spa